Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

NICHOLAS J GOETSCH

Allopathic & Osteopathic Physicians Family Medicine

NPI
1740287614
CMS profile
214566
Location
WATERLOO, IA

General Payments · PY2018–2024

$514,360.63

  • Reported across 429 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$66,695.14

30 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $66,633.84 26
Food and Beverage $61.30 4

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $66,633.84 26
ABBVIE INC. $61.30 4

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $57,906.23 70
PY2019 $82,133.85 78
PY2020 $114,588.62 120
PY2021 $72,763.86 47
PY2022 $72,403.03 57
PY2023 $47,869.90 27
PY2024 $66,695.14 30

Payment records · PY2024 (30)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $14.52 01/05/2024 Food and Beverage Undisputed 01/23/2026 1103807870 CMS
ABBVIE INC. $11.76 03/28/2024 Food and Beverage Undisputed 01/23/2026 1103807872 CMS
ABBVIE INC. $17.95 05/06/2024 Food and Beverage Undisputed 01/23/2026 1103807874 CMS
ABBVIE INC. $17.07 08/22/2024 Food and Beverage Undisputed 01/23/2026 1103807876 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,707.00 01/17/2024 Consulting Fee Undisputed 01/23/2026 1137556909 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,707.00 01/17/2024 Consulting Fee Undisputed 01/23/2026 1137556918 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,707.00 02/14/2024 Consulting Fee Undisputed 01/23/2026 1137556924 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,707.00 02/14/2024 Consulting Fee Undisputed 01/23/2026 1137556929 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,707.00 03/11/2024 Consulting Fee Undisputed 01/23/2026 1137556935 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,707.00 03/11/2024 Consulting Fee Undisputed 01/23/2026 1137556938 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,707.00 04/17/2024 Consulting Fee Undisputed 01/23/2026 1137556945 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,707.00 04/17/2024 Consulting Fee Undisputed 01/23/2026 1137556950 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,707.00 05/10/2024 Consulting Fee Undisputed 01/23/2026 1137556956 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,707.00 05/10/2024 Consulting Fee Undisputed 01/23/2026 1137556962 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,707.00 06/10/2024 Consulting Fee Undisputed 01/23/2026 1137556966 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,707.00 06/10/2024 Consulting Fee Undisputed 01/23/2026 1137556973 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,707.00 07/12/2024 Consulting Fee Undisputed 01/23/2026 1137556979 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,707.00 07/12/2024 Consulting Fee Undisputed 01/23/2026 1137556988 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,353.50 07/15/2024 Consulting Fee Undisputed 01/23/2026 1137556993 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,707.00 08/09/2024 Consulting Fee Undisputed 01/23/2026 1137557000 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,707.00 08/09/2024 Consulting Fee Undisputed 01/23/2026 1137557005 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,707.00 09/11/2024 Consulting Fee Undisputed 01/23/2026 1137557011 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,707.00 09/11/2024 Consulting Fee Undisputed 01/23/2026 1137557014 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,707.00 10/09/2024 Consulting Fee Undisputed 01/23/2026 1137557024 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,707.00 10/09/2024 Consulting Fee Undisputed 01/23/2026 1137557029 CMS
Takeda Pharmaceuticals U.S.A., Inc. $312.34 10/25/2024 Consulting Fee Undisputed 01/23/2026 1137557037 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,707.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 1137557046 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,707.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 1137557052 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,707.00 12/09/2024 Consulting Fee Undisputed 01/23/2026 1137557057 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2,707.00 12/09/2024 Consulting Fee Undisputed 01/23/2026 1137557065 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.